PCI-34051 950762-95-5
Product Description
.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}
Molecular Weight:
296.32 PCI-34051 is a potent and specific HDAC8 inhibitor with IC50 of 10 nM. It has greater than 200-fold selectivity over HDAC1 and 6, more than 1000-fold selectivity over HDAC2, 3, and 10.
Biological Activity
PCI-34051 possesses promising potency for HDAC8 with a Ki of
10 nM. PCI-34051 has high selectivity (approximately fivefold) for HDAC8
relative to the other class I HDACs including HDAC1. PCI-34051 reveals
greater than 200-fold selectivity over HDAC1 and HDAC6, and greater than
1000-fold selectivity over HDAC2, HDAC3 and HDAC10. PCI-34051 inhibits
ovarian tumor line OVCAR-3 with a GI50 of 6 μM and 15% cell death.
Neither significant tubulin nor histone acetylation is observed in the
sensitive cell lines treated with PCI-34051 at concentrations less than
25 μM at 24 hours nor at earlier timepoints. PCI-34051 induces a
selective cytotoxic effect in cell lines derived only from T-cell
malignancies. PCI-34051 induces caspase-dependent Apoptosis.
When
caspase-3 activity is measured at various times after treatment with 5
μM PCI-34051, increasing levels of activity are observed from 12 to 24
to 48 hours, another hallmark of apoptosis, consistent with the higher
levels of caspase activity at this timepoint.
PCI-34051 does not
stimulate Bid cleavage, a characteristic effect of the extrinsic
apoptotic pathway. While P116 and J.RT3-T.5 are sensitive to PCI-34051,
the PLCγ1-deficient J.gamma1 line reveals a marked decrease in the
extent of PCI-34051-induced apoptosis. In addition, steady-state calcium
levels strongly influence the apoptosis induced by PCI-34051. PCI-34051
induces cytochrome c release from mitochondria.
Contact us if you need more details on 950762-95-5. We are ready to answer your questions on packaging, logistics, certification or any Other aspects about PCI-34051 950762-95-5、950762-95-5 PCI-34051. If these products fail to match your need, please contact us and we would like to provide relevant information.
Molecular Weight:
296.32 PCI-34051 is a potent and specific HDAC8 inhibitor with IC50 of 10 nM. It has greater than 200-fold selectivity over HDAC1 and 6, more than 1000-fold selectivity over HDAC2, 3, and 10.
Biological Activity
PCI-34051 possesses promising potency for HDAC8 with a Ki of
10 nM. PCI-34051 has high selectivity (approximately fivefold) for HDAC8
relative to the other class I HDACs including HDAC1. PCI-34051 reveals
greater than 200-fold selectivity over HDAC1 and HDAC6, and greater than
1000-fold selectivity over HDAC2, HDAC3 and HDAC10. PCI-34051 inhibits
ovarian tumor line OVCAR-3 with a GI50 of 6 μM and 15% cell death.
Neither significant tubulin nor histone acetylation is observed in the
sensitive cell lines treated with PCI-34051 at concentrations less than
25 μM at 24 hours nor at earlier timepoints. PCI-34051 induces a
selective cytotoxic effect in cell lines derived only from T-cell
malignancies. PCI-34051 induces caspase-dependent Apoptosis.
When
caspase-3 activity is measured at various times after treatment with 5
μM PCI-34051, increasing levels of activity are observed from 12 to 24
to 48 hours, another hallmark of apoptosis, consistent with the higher
levels of caspase activity at this timepoint.
PCI-34051 does not
stimulate Bid cleavage, a characteristic effect of the extrinsic
apoptotic pathway. While P116 and J.RT3-T.5 are sensitive to PCI-34051,
the PLCγ1-deficient J.gamma1 line reveals a marked decrease in the
extent of PCI-34051-induced apoptosis. In addition, steady-state calcium
levels strongly influence the apoptosis induced by PCI-34051. PCI-34051
induces cytochrome c release from mitochondria.
Contact us if you need more details on 950762-95-5. We are ready to answer your questions on packaging, logistics, certification or any Other aspects about PCI-34051 950762-95-5、950762-95-5 PCI-34051. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : Epigenetics > HDAC Inhibitor
Other Products
Hot Products
Astragaloside AChlortetracycline HCl 64-72-2Paclitaxel 33069-62-4Dexamethasone Acetate 1177-87-3Dinaciclib (SCH727965) 779353-01-4CHIR-124 405168-58-3Ro3280 1062243-51-9TAME 901-47-3CCG-1423 285986-88-110058-F4 403811-55-2Dabigatran (BIBR 953) 211914-51-1H 89 2HCl 130964-39-5T0901317 293754-55-9Aprepitant 170729-80-3Turofexorate Isopropyl (XL335) 629664-81-9BMS-378806 357263-13-9